3-Pyridinecarboxamide, N-[4-(3,5-dimethylphenyl)-5-(4-pyridinyl)-2-thiazolyl]-, hydrochloride (1:2) manufacturers
|
| | 3-Pyridinecarboxamide, N-[4-(3,5-dimethylphenyl)-5-(4-pyridinyl)-2-thiazolyl]-, hydrochloride (1:2) Basic information |
| | 3-Pyridinecarboxamide, N-[4-(3,5-dimethylphenyl)-5-(4-pyridinyl)-2-thiazolyl]-, hydrochloride (1:2) Chemical Properties |
| solubility | Soluble to 20 mM in DMSO with gentle warming | | form | Solid | | color | Light yellow to yellow |
| | 3-Pyridinecarboxamide, N-[4-(3,5-dimethylphenyl)-5-(4-pyridinyl)-2-thiazolyl]-, hydrochloride (1:2) Usage And Synthesis |
| Uses | DPTN is a potent and selective human, mouse, and rat A3AR antagonist with Ki values of 1.65, 9.61, and 8.53nM, respectively[1]. | | Biological Activity | DPTN is a potent and selective A3 adenosine receptor antagonist (Ki values are in the range 0.36 - 1.65 nM (hA3AR) and 1.6 - 8.53 nM (rA3AR)). Reduces intrapulmonary pressure when combined with Dexamethasone . | | IC 50 | hA3: 1.65 nM (Ki) | | storage | Store at -20°C | | References | [1] Zhan-Guo Gao, et al. Pharmacological characterization of DPTN and other selective A3 adenosine receptor antagonist. Purinergic Signal. 2021 Dec;17(4):737-746. DOI:10.1007/s11302-021-09823-5 |
| | 3-Pyridinecarboxamide, N-[4-(3,5-dimethylphenyl)-5-(4-pyridinyl)-2-thiazolyl]-, hydrochloride (1:2) Preparation Products And Raw materials |
|